| Inspired Reports Third Quarter 2024 Results |
Globe Newswire |
11/07 |
16:15 |
| DraftKings Reports Third Quarter Revenue Growth of 39% to $1,095 Million; Introduces Fiscal Year 2025 Revenue Guidance of $6.2 Billion to $6.6 Billion and Reiterates Fiscal Year 2025 Adjusted EBITDA Guidance of $900 Million to $1.0 Billion |
Globe Newswire |
11/07 |
16:15 |
| Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights |
Globe Newswire |
11/07 |
16:02 |
| Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma |
Globe Newswire |
11/07 |
07:30 |
| Sportradar Reports Third Quarter 2024 Financial Results and Further Raises Full Year 2024 Outlook |
Globe Newswire |
11/07 |
07:00 |
| Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update |
Globe Newswire |
11/06 |
16:05 |
| Enterome to Present New Clinical Data and Biomarker Findings for EO2463 at the 2024 American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
11/06 |
06:00 |
| Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024 |
Globe Newswire |
11/05 |
16:01 |
| Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates |
Globe Newswire |
11/05 |
09:05 |
| C4 Therapeutics to Present Data from the Ongoing Phase 1/2 Trial of Cemsidomide in Multiple Myeloma and Non-Hodgkin’s Lymphoma at the American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
11/05 |
09:00 |
| Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations |
Globe Newswire |
11/05 |
09:00 |
| Cellectis Provides Business Updates and Financial Results for Third Quarter 2024 |
Globe Newswire |
11/04 |
16:30 |
| DFW Metro Gains Fifth New Rally House Store in 2024 |
Globe Newswire |
11/01 |
17:42 |
| Mega 97.9 Now Available on TuneIn Premium for Commercial-Free Listening Experience |
Globe Newswire |
10/31 |
08:31 |
| Norwegian Cruise Line Holdings Reports Strong Third Quarter 2024 Financial Results |
Globe Newswire |
10/31 |
07:00 |
| C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights |
Globe Newswire |
10/31 |
07:00 |
| Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update |
Globe Newswire |
10/30 |
16:01 |
| Jet.AI to Participate in Corporate Jet Investor Miami 2024 |
Globe Newswire |
10/29 |
10:00 |
| Cumulus Media and TuneIn Expand Content Partnership Agreement |
Globe Newswire |
10/29 |
08:31 |
| Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution |
Globe Newswire |
10/29 |
07:30 |
| Rally House Opens 5th Houston Area Storefront Location |
Globe Newswire |
10/28 |
11:31 |
| Rogers Communications Reports Third Quarter 2024 Results |
Globe Newswire |
10/24 |
07:00 |
| Sportradar Deepens Official Partnership with NBA with Launch of Innovative, Value-Add Fan Engagement Solutions |
Globe Newswire |
10/22 |
09:00 |
| Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit |
Globe Newswire |
10/21 |
16:00 |
| Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight |
Globe Newswire |
10/21 |
13:00 |
